VALETUDO THERAPEUTICS LLC reported 1 transaction at LIMINATUS PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/14/2026ACC: 0001104659-26-083588
10% Owner
Since Apr 2025
+3.45M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.45M acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+3.45M
Price / share
—
Trade value
—
% of position
192.1%
7/2/2026
1.80M→5.24M
Total
Net shares
+3.45M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 7/2/2026 | J · J | +3.45M | — | — | 192.1% | 1.80M | 5.24M |
| Total | +3.45M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Series A Preferred Stock, par value $0.0001 per share
DirectUnderlying security
Common Stock, par value $0.0001 per share
Underlying shares
489.75M
Shares owned
48.98K
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
489.75M
Owned
48.98K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock, par value $0.0001 per share Direct | Common Stock, par value $0.0001 per share | — | — | 489.75M | 48.98K | |
| Total | 489.75M | 48.98K | ||||